Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Fukushima J Med Sci ; 70(3): 169-173, 2024 Jul 24.
Artigo em Inglês | MEDLINE | ID: mdl-38925956

RESUMO

5-Aminolevulinic acid (5-ALA) is orally administered 2-4 hours before surgery to identify tumor location. Hypotension is sometimes observed after 5-ALA administration. Case reoprtWe present a case of a patient with 5-ALA-induced hypotension that resulted in the development of cerebral infarction. An 83-year-old man with a bladder tumor was scheduled for photodynamic diagnosis-assisted transurethral resection of bladder tumor (PDD-TURBT) and right radical nephroureterectomy. 5-ALA was orally administered and his ordinary antihypertensive and antianginal agents were also administered an hour after 5-ALA administration. Following this, his blood pressure dropped, and he developed muscle weakness and paralysis in his left upper extremity. Magnetic resonance imaging showed evidence of cerebral infarction. ConclusionsWe cannot conclude definitively that our patient's cerebral infarction was solely caused by 5-ALA-induced hypotension because hypotension under these circumstances is not rare. We consider that additional factors, such as patient-specific doses of antihypertensive and antianginal agents may have played a role in the development of his cerebral infarction.


Assuntos
Ácido Aminolevulínico , Hipotensão , Neoplasias da Bexiga Urinária , Humanos , Masculino , Ácido Aminolevulínico/uso terapêutico , Idoso de 80 Anos ou mais , Neoplasias da Bexiga Urinária/cirurgia , Hipotensão/etiologia , Infarto Cerebral/etiologia , Infarto Cerebral/diagnóstico por imagem , Cuidados Pré-Operatórios , Fármacos Fotossensibilizantes/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA